后鼻神经切除术治疗伴过敏性鼻炎的嗜酸性慢性鼻窦炎:疗效研究
研究纳入42例伴过敏性鼻炎的嗜酸性慢性鼻窦炎患者,20例接受功能性内镜鼻窦手术(FESS)联合后鼻神经切除术(PNN),22例仅接受FESS。6个月随访时,联合组在SNOT-22、RQLQ多个维度及Lund-Kennedy评分上较对照组显著改善,术后IL-5浓度更低。结论认为PNN联合FESS安全有效。
要点
- PNN联合FESS可显著改善伴过敏性鼻炎的嗜酸性慢性鼻窦炎患者的主观和客观症状。
- 6个月随访时联合组SNOT-22(p=0.003)、RQLQ活动(p<0.001)、鼻部症状(p=0.003)、眼部症状(p=0.002)、RQLQ总分(p=0.007)均显著低于对照组。
- 联合组术后IL-5浓度较对照组更低(p=0.023)。
核心结论
- PNN联合FESS安全有效,可显著改善伴过敏性鼻炎的嗜酸性慢性鼻窦炎患者的主观和客观症状,细胞因子分析进一步支持该联合方案的疗效。
研究设计与样本
- 研究于2022年12月1日至2024年1月1日从青岛大学附属医院耳鼻咽喉科招募42例伴过敏性鼻炎的嗜酸性慢性鼻窦炎患者。
- 所有患者均接受FESS,其中20例联合PNN为干预组,22例仅行FESS为对照组。
主要发现
- 术前干预组打喷嚏过多和RQLQ情绪影响评分发生率高于对照组(p<0.05)。
- 6个月随访时,干预组SNOT-22(p=0.003)、RQLQ活动(p<0.001)、鼻部症状(p=0.003)、眼部症状(p=0.002)、RQLQ总分(p=0.007)及Lund-Kennedy评分(p<0.001)较对照组显著降低。
- 干预组眼部症状(p=0.002)、情绪(p=0.002)及改良Lund-Kennedy评分(p<0.001)的下降幅度(Δ)大于对照组。
- 干预组术后IL-5浓度低于对照组(p=0.023)。
关键数值与推荐
- 主观症状采用视觉模拟量表(VAS)、鼻窦结局测试-22(SNOT-22)和鼻结膜炎生活质量问卷(RQLQ)评估。
- 客观评估包括改良Lund-Kennedy内镜评分和Lund-Mackay CT评分。
- 术后收集鼻分泌物,采用酶联免疫吸附试验(ELISA)进行细胞因子分析。
临床怎么用
- 原文结论认为PNN联合FESS安全有效,可显著改善伴过敏性鼻炎的嗜酸性慢性鼻窦炎患者的主观和客观症状。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy of posterior nasal neurectomy (PNN) in patients with eosinophilic chronic rhinosinusitis (eCRS) and moderate to severe persistent allergic rhinitis (AR). METHODS: A total of 42 patients with eCRS and AR were recruited from the Otorhinolaryngology Department of Qingdao University Affiliated Hospital between December 1, 2022, and January 1, 2024. All patients underwent functional endoscopic sinus surgery (FESS), with 20 receiving additional PNN (intervention group) and 22 undergoing FESS alone (control group). Subjective symptoms were assessed using the visual analog scale (VAS), sino-nasal outcome test-22 (SNOT-22), and rhinoconjunctivitis quality of life questionnaire (RQLQ). Objective assessments included the modified Lund-Kennedy endoscopic score and Lund-Mackay CT score. Postoperative nasal secretions were collected for cytokine analysis using enzyme-linked immunosorbent assay (ELISA). RESULTS: Preoperatively, the intervention group exhibited higher rates of excessive sneezing and emotional impact on RQLQ scores (p < 0.05). At 6-month follow-up, the intervention group showed significantly reduced subjective symptom scores (SNOT-22, p = 0.003; RQLQ activity, p < 0.001; nasal symptoms, p = 0.003; eye symptoms, p = 0.002; total RQLQ score, p = 0.007) and improved objective symptoms (Lund-Kennedy score, p < 0.001) compared to the control group. Greater reductions (Δ) were observed in eye symptoms (p = 0.002), emotional (p = 0.002), and Modified Lund-Kennedy score (p < 0.001). Postoperative IL-5 concentrations were lower in the intervention group (p = 0.023). CONCLUSIONS: Concurrent PNN with FESS is both safe and effective, leading to significant improvements in both subjective and objective symptoms in eCRS patients with AR. Cytokine analysis further supports the therapeutic benefits of this combined approach.
引用
- Li S, Wang L, Cui X, et al. Posterior Nasal Neurectomy for Eosinophilic Chronic Rhinosinusitis With Allergic Rhinitis: Efficacy Study. Laryngoscope. 2025. PMID: 40407196. doi:10.1002/lary.32294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。